Correlation Between Telix Pharmaceuticals and Oncology Pharma
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Oncology Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Oncology Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Oncology Pharma, you can compare the effects of market volatilities on Telix Pharmaceuticals and Oncology Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Oncology Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Oncology Pharma.
Diversification Opportunities for Telix Pharmaceuticals and Oncology Pharma
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Telix and Oncology is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Oncology Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Pharma and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Oncology Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Pharma has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Oncology Pharma go up and down completely randomly.
Pair Corralation between Telix Pharmaceuticals and Oncology Pharma
Assuming the 90 days horizon Telix Pharmaceuticals is expected to generate 157.01 times less return on investment than Oncology Pharma. But when comparing it to its historical volatility, Telix Pharmaceuticals Limited is 111.09 times less risky than Oncology Pharma. It trades about 0.22 of its potential returns per unit of risk. Oncology Pharma is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 0.00 in Oncology Pharma on September 3, 2024 and sell it today you would earn a total of 0.01 from holding Oncology Pharma or generate 9.223372036854776E16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Telix Pharmaceuticals Limited vs. Oncology Pharma
Performance |
| Timeline |
| Telix Pharmaceuticals |
| Oncology Pharma |
Telix Pharmaceuticals and Oncology Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Telix Pharmaceuticals and Oncology Pharma
The main advantage of trading using opposite Telix Pharmaceuticals and Oncology Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Oncology Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Pharma will offset losses from the drop in Oncology Pharma's long position.| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
| Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Therapeutic Solutions International | Oncology Pharma vs. Alpha Cognition |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |